restasis- cyclosporine emulsion
physicians total care, inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 0.5 mg in 1 ml - restasis ® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. restasis ® is contraindicated in patients with active ocular infections and in patients with known or suspected hypersensitivity to any of the ingredients in the formulation.
optimmune ophthalmic- cyclosporine ointment
merck sharp & dohme corp. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 2 mg in 1 g - optimmune® ophthalmic ointment is indicated for management of chronic keratoconjunctivitis sicca (kcs) and chronic superficial keratitis (csk) in dogs.
cyclosporine a powder
ax pharmaceutical corp - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) -
aqua-stasis cyclosporine-a liquid
dr marc's manufacturing and sales - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 0.0005 g in 100 ml
cyclo-derm cyclosporine-a liquid
dr marc's manufacturing and sales - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 0.25 g in 100 ml
nail cyclosporin-a cyclosporine-a liquid
dr marc's manufacturing and sales - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 0.25 g in 100 ml
hydro-stasis cyclosporine-a liquid
dr marc's manufacturing and sales - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 0.0005 g in 100 ml
cyclosporine capsule
sandoz canada incorporated - cyclosporine - capsule - 25mg - cyclosporine 25mg - immunosuppressive agents
restasis- cyclosporine emulsion
a-s medication solutions - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - restasis ® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. restasis ® is contraindicated in patients with known or suspected hypersensitivity to any of the ingredients in the formulation. risk summary clinical administration of cyclosporine ophthalmic emulsion 0.05% is not detected systemically following topical ocular administration [see clinical pharmacology ( 12.3 ) ], and maternal use is not expected to result in fetal exposure to the drug. oral administration of cyclosporine to pregnant rats or rabbits did not produce teratogenicity at clinically relevant doses [see data ]. data animal data at maternally toxic doses (30 mg/kg/day in rats and 100 mg/kg/day in rabbits), cyclosporine oral solution (usp) was teratogenic as indicated by i
cyclavance- cyclosporine oral solution solution
virbac ah inc - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclavance is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs (1.8 kg) body weight. cyclavance is contraindicated for use in dogs with a history of neoplasia. do not use in dogs with a hypersensitivity to cyclosporine.